DAVID M. TANEN

Profile

First Name

: DAVID

Middle Name

: M.

Last Name

: TANEN

Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER, DIRECTOR
NILE THERAPEUTICS, INC.
DEBORAH ASCHEIM, ARIE S. BELLDEGRUN, ANTHONY BERGMANN, RICHARD B. BREWER, EARL COLLIER, EARL COLLIER, JR., ANTHONY DAVIES, GEORGE DUNBAR, DARON EVANS, LELAND GERSHELL, PEDRO GRANADILLO, LOUIS GRASMICK, ANDREW HAMER, PETER M. KASH, JOSHUA KAZAM, JOSHUA A KAZAM, JOSHUA A. KAZAM, KAREN KRASNEY, HSIAO D. LIEU, FRANK LITVACK, LOUIS MANZO, LINDA MARBAN, PAUL A. MIEYAL, PAUL A. MIEYAL, PH.D., DAVID MUSKET, GREGORY SCHAFER, GREGORY W. SCHAFER, RACHEL SMITH
EXECUTIVE OFFICER, DIRECTOR
ARNO THERAPEUTICS, INC
ARIE S. BELLDEGRUN, ARIE S. BELLDEGRUN, M.D., ROBERT I. FALK, WILLIAM F. HAMILTON, WILLIAM F. HAMILTON, PH.D., TOMER KARIV, PETER M. KASH, JOSHUA A. KAZAM, GLENN R. MATTES, JAY MOORIN, SCOTT L. NAVINS, STEFAN PRONIUK, PH.D., YACOV REIZMAN, STEVEN B. RUCHEFSKY, RANDY H. THURMAN, ALEXANDER ZUKIWSKI, M.D.
DIRECTOR, PROMOTER
VETERINARY PRIME, INC.
RON BELLDEGRUN, ALEX KAUFMAN, JOSHUA A. KAZAM, GREGORY F. KIERNAN, CHRISTOPHER WILFONG
EXECUTIVE OFFICER
ALLOGENE THERAPEUTICS, INC.
ROBERT ABRAHAM, ARIE BELLDEGRUN, DAVID BONDERMAN, DAVID CHANG, JOHN DEYOUNG, FRANZ HUMER, JOSHUA A. KAZAM, TODD SISITSKY, OWEN WITTE
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
KRONOS BIO, INC.
SEAN ALGEO, ARIE S. BELLDEGRUN, M.D., REBECKA BELLDEGRUN, M.D., NORBERT BISCHOFBERGER, PH.D., PHILIP GUTRY, JOSHUA A. KAZAM, JACOB LOVEN, JOHN C. MARTIN, PH.D., OTELLO STAMPACCHIA, PH.D., CHRISTOPHER WILFONG
DIRECTOR, PROMOTER
NEOGENE THERAPEUTICS, INC.
FEI CHEN, FRANZ HUMER, RAJUL JAIN, HELEN KIM, CARSTEN LINNEMANN, PHD, RACHEL MEARS, ELISA PETRIS, ANTONIUS N.M. SCHUMACHER, CAROLINE STOUT, DAVID TANEN, KATHERINE WOOD
EXECUTIVE OFFICER, PROMOTER
ICONOVIR BIO, INC.
SEAN ALGEO, ARIE S. BELLDEGRUN, DAVID CHANG, JOHN HUYNH, WILLIAM KAELIN, JOSHUA KAZAM, JOSHUA A. KAZAM, HELEN S. KIM, JAKOB LOVEN, JULIE MALTZMAN, MARK A. MCCAMISH, HEBA NOWYHED, NICOLE VAN DE LEUV
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-06-04
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2023-06-06 
2023-06-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2023-06-06 
2020-12-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-01 
2019-07-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-07-01 
2019-05-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-05-10 
2018-06-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-05-22 
2018-04-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-04-06 
2017-02-15
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2017-01-27 
2016-08-30
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2016-08-15 
2013-11-13
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2013-10-29 
2012-12-06
D/A
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity, Debt 
2012-11-26 
2012-12-05
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity, Debt 
2012-11-26 
2010-09-23
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2010-09-09 
2009-07-15
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2009-07-07